XChange TEC.INC
XHG Nasdaq Insurance Agents, Brokers & Service Financials FY2017โFY2025
What XChange TEC.INC does
No business description yet.
- Legal name
- XChange TEC.INC
- Fiscal year ends
- September 30, 2025
- Latest annual report
- 20-F ยท Jan 14, 2026
- Accession ยท CIK
- 0001213900-26-004379
0001769256
Revenue and margins
XChange TEC.INC had $50.6M of revenue in fiscal 2025, up 26.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ in fiscal 2025, โ of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
XChange TEC.INC returned โ to shareholders in fiscal 2025. The diluted share count rose 20,993.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably XChange TEC.INC can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.5M | $0.1M | $0.0M | $1.4M | $1.8M |
| Debt incl. finance leases | $83.0M | $0.9M | $6.1M | $4.6M | $4.6M |
| Net debt / EBITDA | 10.1x | โ | โ | โ | โ |
| Interest coverage | โ0.3x | โ0.7x | โ15.0x | โ22.6x | โ26.2x |
| Current ratio | 0.1x | 0.1x | 0.1x | 0.1x | 0.0x |
| Quick ratio | 0.1x | 0.1x | 0.1x | 0.1x | 0.0x |
| Total assets | $58.4M | $13.4M | $11.7M | $112M | $9.7M |
| Total liabilities | $443M | $93.9M | $99.9M | $191M | $133M |
| Shareholders' equity | โ$386M | โ$80.5M | โ$88.1M | โ$79.4M | โ$124M |
| Net debt (โ = net cash) | $80.5M | $0.8M | $6.0M | $3.1M | $2.8M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 5 | 4 / 9 | 4 / 9 | 4 / 9 | 5 / 9 | 3 / 8 | 4 / 8 | 2 / 9 |
| Accruals ratio | โ | โ22.6% | โ23.3% | โ120.3% | โ77.0% | 367.3% | โ35.4% | โ48.8% | โ168.3% |
| Altman Z'' | โ | โ10.59 | โ10.78 | โ40.42 | โ76.91 | โ165.58 | โ190.28 | โ32.07 | โ372.21 |
9 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | $76.7M | $136M | $179M | $172M | $159M | $99.6M | $0.0M | $40.0M | $50.6M |
| Net interest income | โ | โ | โ | โ | โ$3.7M | โ$3.8M | $0.0M | โ | โ |
| Gross profit | โ$3.7M | โ$1.2M | โ$10.4M | $0.6M | $13.3M | โ$9.0M | โ | $1.9M | $1.1M |
| Research and development | $6.5M | $7.9M | $6.8M | $3.6M | $1.2M | $0.0M | $0.0M | $0.0M | โ |
| Operating income | โ$27.8M | โ$65.2M | โ$65.2M | โ$214M | โ$4.2M | โ$4.5M | โ$3.3M | โ$81.7M | โ$99.9M |
| Interest expense | โ | $14.2M | $16.6M | $19.1M | $15.9M | $6.4M | $0.2M | $3.6M | $3.8M |
| Pretax income | โ$35.9M | โ$76.1M | โ$72.4M | โ$219M | โ$20.1M | โ$75.6M | โ$3.6M | โ$85.0M | โ$104M |
| Income tax | $0.1M | $0.4M | $0.0M | $0.0M | $0.0M | $0.0M | โ | $0.1M | $0.0M |
| Net income | โ$36.0M | โ$76.4M | โ$72.4M | โ$219M | โ$87.5M | $125M | โ$10.1M | โ$31.5M | โ$104M |
| Net income to common | โ$44.7M | โ$97.1M | โ$117M | โ$219M | โ$87.5M | $125M | โ$10.1M | โ$31.5M | โ$104M |
| Diluted EPS | โ$0.13 | โ$0.24 | โ$0.27 | โ$0.16 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted shares | 0.35B | 0.41B | 0.43B | 1.35B | 146.07B | 1,025.84B | 0.03B | 0.24B | 50.25B |
| Cash flow | |||||||||
| Cash from operations | โ$6.4M | โ$17.9M | โ$12.8M | $7.8M | โ$16.9M | โ$6.8M | โ$5.7M | โ$1.4M | โ$1.6M |
| Capital expenditure | $40.2M | $103M | $49.7M | $14.2M | $0.0M | โ | โ | โ | โ |
| Free cash flow | โ$46.6M | โ$121M | โ$62.5M | โ$6.3M | โ$16.9M | โ | โ | โ | โ |
| Depreciation and amortization | $14.9M | $23.3M | $31.3M | $37.5M | $12.2M | $4.2M | โ | $0.0M | โ |
| Stock-based compensation | $0.1M | $0.3M | $1.2M | $2.3M | $2.4M | $1.5M | $0.7M | $0.3M | โ |
| Balance sheet | |||||||||
| Cash and short-term investments | $54.9M | $15.1M | $22.4M | $3.4M | $2.5M | $0.1M | $0.0M | $1.4M | $1.8M |
| Total debt | โ | $40.9M | $90.2M | $118M | $83.0M | $0.9M | $6.1M | $4.6M | $4.6M |
| Current assets | โ | $65.1M | $83.5M | $29.8M | $27.3M | $10.0M | $11.7M | $9.6M | $5.6M |
| Current liabilities | โ | $286M | $238M | $288M | $363M | $93.9M | $99.9M | $191M | $133M |
| Property and equipment, net | โ | $192M | $166M | $52.6M | $6.0M | $0.1M | โ | $0.0M | $0.0M |
| Goodwill | โ | โ | โ | โ | โ | โ | โ | $101M | $3.3M |
| Intangible assets | โ | $0.2M | $0.2M | $32.6M | $23.6M | $1.9M | โ | โ | $0.1M |
| Total assets | โ | $259M | $252M | $125M | $58.4M | $13.4M | $11.7M | $112M | $9.7M |
| Total liabilities | โ | $372M | $365M | $418M | $443M | $93.9M | $99.9M | $191M | $133M |
| Shareholders' equity | โ$119M | โ$209M | โ$314M | โ$294M | โ$386M | โ$80.5M | โ$88.1M | โ$79.4M | โ$124M |
| Margins | |||||||||
| Gross margin | โ4.8% | โ0.9% | โ5.8% | 0.4% | 8.4% | โ9.0% | โ | 4.7% | 2.2% |
| Operating margin | โ36.3% | โ47.9% | โ36.3% | โ124.2% | โ2.6% | โ4.5% | โ98,126.5% | โ204.2% | โ197.2% |
| EBITDA margin | โ16.8% | โ30.8% | โ18.9% | โ102.5% | 5.0% | โ0.3% | โ | โ204.2% | โ |
| Net margin | โ47.0% | โ56.2% | โ40.4% | โ127.0% | โ54.9% | 125.7% | โ297,302.9% | โ78.7% | โ204.9% |
| FCF margin | โ60.8% | โ88.9% | โ34.8% | โ3.7% | โ10.6% | โ | โ | โ | โ |
| Net interest share of revenue | โ | โ | โ | โ | โ2.3% | โ3.8% | 100.0% | โ | โ |
| Returns | |||||||||
| Return on capital employed | โ | 238.0% | โ453.7% | 131.2% | 1.4% | 5.6% | 3.8% | 103.1% | 80.8% |
| Return on assets | โ | โ29.5% | โ28.4% | โ116.1% | โ95.4% | 348.4% | โ80.4% | โ51.0% | โ171.0% |
| Growth | |||||||||
| Revenue growth | โ | 77.3% | 31.9% | โ3.9% | โ7.6% | โ37.5% | โ100.0% | 1,177,041.2% | 26.5% |
| Net income growth | โ | โ | โ | โ | โ | โ | โ108.1% | โ | โ |
| Share count change | โ | 15.4% | 5.1% | 213.9% | 10,710.9% | 602.3% | โ100.0% | 749.3% | 20,993.4% |
| Financial health | |||||||||
| Net debt / EBITDA | โ | โ | โ | โ | 10.1x | โ | โ | โ | โ |
| Interest coverage | โ | โ4.6x | โ3.9x | โ11.2x | โ0.3x | โ0.7x | โ15.0x | โ22.6x | โ26.2x |
| Current ratio | โ | 0.2x | 0.4x | 0.1x | 0.1x | 0.1x | 0.1x | 0.1x | 0.0x |
| Quick ratio | โ | 0.2x | 0.4x | 0.1x | 0.1x | 0.1x | 0.1x | 0.1x | 0.0x |
| Capital allocation | |||||||||
| Capex / revenue | 52.4% | 75.8% | 27.7% | 8.2% | 0.0% | โ | โ | โ | โ |
| Stock comp / revenue | 0.1% | 0.3% | 0.7% | 1.3% | 1.5% | 1.5% | 19,935.3% | 0.9% | โ |
| Quality scores | |||||||||
| Piotroski F-score | โ | โ | 4.0 | 4.0 | 4.0 | 5.0 | 3.0 | 4.0 | 2.0 |
| Altman Z'' | โ | โ10.6 | โ10.8 | โ40.4 | โ76.9 | โ165.6 | โ190.3 | โ32.1 | โ372.2 |
| Accruals ratio | โ | โ22.6% | โ23.3% | โ120.3% | โ77.0% | 367.3% | โ35.4% | โ48.8% | โ168.3% |
Source: SEC EDGAR XBRL filings (CIK 0001769256). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in CNY under US GAAP and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. The ADS ratio could not be read from the filing, so market cap and valuation are not shown. For information only โ not investment advice. Check the original filings before relying on any figure.
